Gynecology status update: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{CMG}}; {{AE}} {{Hudakarman}}
{{CMG}}; {{AE}} {{Hudakarman}}
{{Organ System Project}}
{{Organ System Project}}
System Leader: '''[[User:Huda Karman|Huda Karman, M.D.]]'''
System Leader: '''[[User:Huda Karman|Huda Karman, M.D.]]'''
== Status Updates ==
==Status Updates==
{| border="1" cellpadding="5" cellspacing="0" align="center" |class="wikitable"class="wikitable"
{| class="wikitable" border="1" cellpadding="5" cellspacing="0" align="center" |class="wikitable"
|+
|+
! colspan="2" style="background:#efefef;" |Resident survival guide Progress
! colspan="2" style="background:#efefef;" |Resident survival guide Progress
|-
|-
|Completed
|Completed
|1
|1
|-
|-
|In progress  
|In progress
|1
|1
|-
|-
|Remaining  
|Remaining
|
|
|-
|-
! colspan="2" style="background:#efefef;" |Primary care chapter Progress
! colspan="2" style="background:#efefef;" |Primary care chapter Progress
|-
|-
|Completed
|Completed
|
|
|-
|-
|In progress  
|In progress
|
|
|-
|-
|Remaining  
|Remaining
|
|
|}
|}
Line 52: Line 53:
|
|
|[[Dyspareunia resident survival guide]]
|[[Dyspareunia resident survival guide]]
|Mydah
|Roghayeh
|Will start at 30 August
|
|-
|-
|[[Vulvovaginitis]]  
|[[Vulvovaginitis]]
|
|
|
|
Line 127: Line 128:


==Status Update==
==Status Update==
{| border="1" cellpadding="5" cellspacing="0" align="center" |class="wikitable"class="wikitable"
{| class="wikitable" border="1" cellpadding="5" cellspacing="0" align="center" |class="wikitable"
|+
|+
! colspan="2" style="background:#efefef;" |Progress
! colspan="2" style="background:#efefef;" |Progress
|-
|-
|Completed
|Completed
|
|
|-
|-
|In progress  
|In progress
|
|
|-
|-
|Remaining  
|Remaining
|
|
|}
|}




== List of Chapters Requiring Content ==
==List of Chapters Requiring Content==


{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
Line 165: Line 166:
| style="padding: 5px 5px; background: #F5F5F5;" |Pelvic organ prolapse
| style="padding: 5px 5px; background: #F5F5F5;" |Pelvic organ prolapse


* Vaginal prolapse
*Vaginal prolapse
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 184: Line 185:
| style="padding: 5px 5px; background: #F5F5F5;" |Cervical Neoplasia
| style="padding: 5px 5px; background: #F5F5F5;" |Cervical Neoplasia


*  
*
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 273: Line 274:
|-
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Ovarian cancer  
| style="padding: 5px 5px; background: #F5F5F5;" |Ovarian cancer
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 282: Line 283:
|-
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Genital warts  
| style="padding: 5px 5px; background: #F5F5F5;" |Genital warts
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 368: Line 369:
| rowspan="22" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Gynecology
| rowspan="22" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Gynecology
| style="padding: 5px 5px; background: #F5F5F5;" |Precocious puberty
| style="padding: 5px 5px; background: #F5F5F5;" |Precocious puberty
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned  
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Eman  
| style="padding: 5px 5px; background: #F5F5F5;" |Eman
| style="padding: 5px 5px; background: #F5F5F5;" |Huda  
| style="padding: 5px 5px; background: #F5F5F5;" |Huda
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 377: Line 378:
| style="padding: 5px 5px; background: #F5F5F5;" |Infertility
| style="padding: 5px 5px; background: #F5F5F5;" |Infertility
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Asia  
| style="padding: 5px 5px; background: #F5F5F5;" |Asia
| style="padding: 5px 5px; background: #F5F5F5;" |Huda  
| style="padding: 5px 5px; background: #F5F5F5;" |Huda
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 386: Line 387:
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Rahmah
| style="padding: 5px 5px; background: #F5F5F5;" |Rahmah
| style="padding: 5px 5px; background: #F5F5F5;" |Huda  
| style="padding: 5px 5px; background: #F5F5F5;" |Huda
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 394: Line 395:
| style="padding: 5px 5px; background: #F5F5F5;" |Vaginal Discharge
| style="padding: 5px 5px; background: #F5F5F5;" |Vaginal Discharge
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Samah  
| style="padding: 5px 5px; background: #F5F5F5;" |Samah
| style="padding: 5px 5px; background: #F5F5F5;" |Huda  
| style="padding: 5px 5px; background: #F5F5F5;" |Huda
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 577: Line 578:
| style="padding: 5px 5px; background: #F5F5F5;" |Amenorrhea
| style="padding: 5px 5px; background: #F5F5F5;" |Amenorrhea
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" | [[User:Eiman|Eiman Ghaffarpasand]]
| style="padding: 5px 5px; background: #F5F5F5;" |[[User:Eiman|Eiman Ghaffarpasand]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |

Revision as of 23:27, 28 August 2020


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Huda A. Karman, M.D.

Organ System Project
Topics
Leaders & Members
Meetings' Summary

System Leader: Huda Karman, M.D.

Status Updates

Resident survival guide Progress
Completed 1
In progress 1
Remaining
Primary care chapter Progress
Completed
In progress
Remaining

Primary Care Topics

Primary Care Cahpters Primary care Resident Survival guides
Topics Author Status Resident survival guides Author Status
Hypogastric pain Hypogastric pain resident survival guide
Dyspareunia Dyspareunia resident survival guide Roghayeh
Vulvovaginitis Vulvovaginitis resident survival guide
- Birth control/Contraception resident survival guide Huda Karman In progress
Chronic pelvic pain Chronic pelvic pain resident survival guide
Menopause Menopause resident survival guide
- Pelvic organ prolapse resident survival guide
Cervical cancer screening Tayyaba Ali Complete
Menstrual cycle Menstrual disorders resident survival guide
- Sexual violence resident survival guide
Sexual dysfunction Sexual dysfunction resident survival guide
Infertility Infertility resident survival guide

Status Update

Progress
Completed
In progress
Remaining


List of Chapters Requiring Content

Category Chapters that need content Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Gynecology
Pelvic organ prolapse
  • Vaginal prolapse
Urinary Incontinence
Cervical Neoplasia
Endometrial Neoplasia
STDs (LP)
Pelvic Inflammatory Disease
Family Planning
Contraception
Abnormal Vaginal Bleeding
Precocious Puberty
Hirsutism
Breast Cancer (LP)
Ovarian cancer
Genital warts

In progress chapters

Category Chapters that need content Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Gynecology Precocious puberty Assigned Eman Huda
Infertility Assigned Asia Huda
Menopause Assigned Rahmah Huda
Vaginal Discharge Assigned Samah Huda

Completed chapters

Category Chapters that need content Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Gynecology Amenorrhea Eiman Ghaffarpasand
Polycystic ovary syndrome Aditya